SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 61 filers reported holding SAVARA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $109,000 | -56.2% | 100,000 | 0.0% | 0.00% | -71.4% |
Q2 2020 | $249,000 | +17.5% | 100,000 | 0.0% | 0.01% | -22.2% |
Q1 2020 | $212,000 | -52.7% | 100,000 | 0.0% | 0.01% | -40.0% |
Q4 2019 | $448,000 | -15.5% | 100,000 | -50.0% | 0.02% | -28.6% |
Q3 2019 | $530,000 | +11.8% | 200,000 | 0.0% | 0.02% | +90.9% |
Q2 2019 | $474,000 | -35.7% | 200,000 | +100.0% | 0.01% | -52.2% |
Q1 2019 | $737,000 | -2.6% | 100,000 | 0.0% | 0.02% | -23.3% |
Q4 2018 | $757,000 | -32.2% | 100,000 | 0.0% | 0.03% | +25.0% |
Q3 2018 | $1,116,000 | +58.3% | 100,000 | +110.5% | 0.02% | +84.6% |
Q4 2017 | $705,000 | – | 47,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 4,980,804 | $16,026,005 | 46.25% |
NEA Management Company, LLC | 24,137,931 | $77,120,690 | 5.89% |
Bain Capital Life Sciences Investors, LLC | 11,622,598 | $37,134,201 | 3.82% |
VR Adviser, LLC | 6,351,531 | $20,293,142 | 3.24% |
Sio Capital Management, LLC | 1,010,701 | $3,229,190 | 0.82% |
ACUTA CAPITAL PARTNERS, LLC | 198,139 | $633,054 | 0.43% |
FARALLON CAPITAL MANAGEMENT LLC | 10,908,086 | $34,851,335 | 0.18% |
Parkman Healthcare Partners LLC | 206,607 | $660,109 | 0.11% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,064,551 | $19,376,240 | 0.04% |
ClariVest Asset Management LLC | 242,900 | $776 | 0.04% |